000 | 01112 a2200277 4500 | ||
---|---|---|---|
005 | 20250517110128.0 | ||
264 | 0 | _c20171204 | |
008 | 201712s 0 0 eng d | ||
022 | _a1873-4286 | ||
024 | 7 |
_a10.2174/1381612822666160726112115 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStrazielle, Nathalie | |
245 | 0 | 0 |
_aPotential Pathways for CNS Drug Delivery Across the Blood-Cerebrospinal Fluid Barrier. _h[electronic resource] |
260 |
_bCurrent pharmaceutical design _c2016 |
||
300 |
_a5463-5476 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aBiological Transport _xdrug effects |
650 | 0 | 4 |
_aBlood-Brain Barrier _xdrug effects |
650 | 0 | 4 |
_aCentral Nervous System _xdrug effects |
650 | 0 | 4 |
_aCerebrospinal Fluid _xdrug effects |
650 | 0 | 4 | _aDrug Delivery Systems |
650 | 0 | 4 | _aHumans |
700 | 1 | _aGhersi-Egea, Jean-François | |
773 | 0 |
_tCurrent pharmaceutical design _gvol. 22 _gno. 35 _gp. 5463-5476 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/1381612822666160726112115 _zAvailable from publisher's website |
999 |
_c26271969 _d26271969 |